Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis

Haematologica

Volumn 96, Issue 8, 2011, Pages 1121-1127

  Ondrejka, Sarah L ^a   Lai, Raymond ^b   Smith, Stephen D ^c   Hsi, Eric D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CROSS CANCER INSTITUTE   (Canada)

^c TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Indolent; Leukemia; Mantle cell lymphoma; Monoclonal B cell lymphocytosis; SOX11

Indexed keywords

ALEMTUZUMAB; BENDAMUSTINE; BORTEZOMIB; CD19 ANTIGEN; CD20 ANTIGEN; CD23 ANTIGEN; CD5 ANTIGEN; CYCLIN D1; CYCLOPHOSPHAMIDE; EOSIN; FLUDARABINE; HEMATOXYLIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; PENTOSTATIN; PREDNISONE; RASBURICASE; RITUXIMAB; TEMSIROLIMUS; TRANSCRIPTION FACTOR SOX11; VINCRISTINE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW BIOPSY; BONE MARROW DISEASE; CANCER MORTALITY; CHROMOSOME 11Q; CHROMOSOME 14Q; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 14; CLINICAL ARTICLE; CYTOGENETICS; DISEASE FREE SURVIVAL; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARYOTYPE; LYMPHOCYTOSIS; MALE; MANTLE CELL LYMPHOMA; MORPHOLOGY; MULTIPLE CYCLE TREATMENT; PREVALENCE; PROGNOSIS; PROTEIN EXPRESSION;

AGED; ANTIGENS, CD; BONE MARROW; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; LYMPHOCYTOSIS; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; SOXC TRANSCRIPTION FACTORS;

EID: 79960547464     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2010.036277     Document Type: Article

References (28)

1. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood. 1997;89(11):3909-18.
2. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumours of the Haematopoietic and Lymph oid Tissues. 229-32. 2008. Lyon, IARC.
3. Jares P, Colomer D, Campo E. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer. 2007;7(10):750-62.
4. Espinet B, Sole F, Pedro C, Garcia M, Bellosillo B, Salido M, et al. Clonal proliferation of cyclin D1-positive mantle lymphocytes in an asymptomatic patient: an earlystage event in the development or an indolent form of a mantle cell lymphoma? Hum Pathol. 2005;36(11):1232-7.
5. Nodit L, Bahler DW, Jacobs SA, Locker J, Swerdlow SH. Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes. Hum Pathol. 2003;34(10):1030-4.
6. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med. 1993; 329 (14):987-94.
7. Martin P, Chadburn A, Christos P, Weil K, Furman RR, Ruan J, et al. Outcome of deferred initial therapy in mantle-cell lymphoma. J Clin Oncol. 2009;27(8):1209-13.
8. Vizcarra E, Martínez-Climent JA, Benet I, Marugan I, Terol MJ, Prosper F, et al. Identification of two subgroups of mantle cell leukemia with distinct clinical and biological features. Hematol J. 2001;2(4):234-41.
9. Fernàndez V, Salamero O, Espinet B, Solé F, Royo C, Navarro A, et al. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res 2010;70(4):1408-18.
10. Orchard J, Garand R, Davis Z, Babbage G, Sahota S, Matutes E, et al. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood. 2003;101(12): 4975-81.
11. Ek S, Dictor M, Jerkeman M, Jirstom K, Borrebaeck CA. Nuclear expresison of the non-B cell lineage SOX11 transcription factor identifies mantle cell lymphoma. Blood. 2008;111(2):800-5.
12. Frater JL, Tsiftsakis EK, Hsi ED, Pettay J, Tubbs RR. Use of novel t(11;14) and t(14;18) dual-fusion fluorescence in situ hybridization probes in the differential diagnosis of lymphomas of small lymphocytes. Diagn Mol Pathol. 2001;10(4)214-22.
13. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias: French-American-British (FAB) Cooperative Group. J Clin Pathol. 1989;42 (6):567-84
14. Argatoff LH, Connors JM, Klasa RJ, Horsman DE, Gascoyne RD. Mantle cell lymphoma: A clinicopathologic study of 80 cases. Blood. 1997;89(6):2067-78.
15. Bosch F, Lopez-Guillermo A, Campo E, Ribera JM, Conde E, Piris MA, et al. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors. Cancer 1998;82(3): 567-75.
16. Cohan PL, Kurtin PJ, Donovan KA, Hanson CA. Bone marrow and peripheral blood involvement in mantle cell lymphoma. Br J Haematol. 1998;101(2):302-10.
17. Ferrer A, Salaverria I, Bosch F, Villamor N, Rozman M, Beà S, et al. Leukemic involvement is a common feature in mantle cell lymphoma. Cancer. 2007;109(12):2473-80.
18. Oinonen R, Franssila K, Teerenhovi L, Lappalainen K, Elonen E. Mantle cell lymphoma: clinical features, treatment and prognosis of 94 patients. Eur J Cancer. 1998; 34(3):329-36.
19. Samaha H, Dumontet C, Ketterer N, Moullet I, Thieblemont C, Bouafia F, et al. Mantle cell lymphoma: a retrospective study of 121 cases. Leukemia. 1998;12(8): 1281-7.
20. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94(6):1848-54.
21. Dictor M, Ek S, Sundberg M, Warenholt J, György C, Sernbo S, et al. Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma. Haematologica. 2009;94(11):1563-8.
22. Wang X, Björklund S, Wasik AM, Grandien A, Andersson P, Kimby E, et al. Gene expression profiling and chromoprecipitation identify DBN1, SETMAR, and HIG2 as direct targets of SOX11 in mantle cell lymphoma. PLoS One 2010;5(11): e14085.
23. Gustavsson E, Sernbo S, Andersson E, Brennan DJ, Dictor M, Jerkeman M, et al. SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies. Mol Cancer. 2010;9:187.
24. Wang X, Asplund AC, Porwit A, Flygare J, Smith CI, Christensson B, et al. The subcellular SOX11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival. Br J Haematol 2008;143(2):248-52.
25. Mozos A, Royo C, Hartmann E, De Jong D, Baró C, Valera A, et al. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1 negative subtype. Haematologica 2009;94(11):1555-62.
26. Wasman J, Rosenthal NS, Farhi DC. Mantle cell lymphoma: morphologic findings in bone marrow involvement. Am J Clin Pathol. 1996;106(2):196-200.
27. Hoster E, Dreyling M, Klapper W, Gisselbrecht C, van Hoof A, Kluin-Nele-mans HC, et al. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood. 2008;111(2): 558-65.
28. Lecluse Y, Lebailly P, Roulland S, Gac A-C, Nadel B, Gauduchon P. t(11;14)-positive clones can persist over a long period of time in the peripheral blood of healthy individuals. Leukemia. 2009;23(6):1190-3.